AKT1 and neoplasm: B cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a direct target of miR-15 and via regulating BMI1 through PI3K/Akt pathway, miR-15 inhibited in vivo BLCA cell progression and tumor growth.